SAB Biotherapeutics paid its 4 named executives $22.4M in total in FY2025 (Dec). CEO Samuel J. Reich was paid $9.4M of that.
Pay$100 in the stock at the end of FY21 → $5
Pay of each named executive
Samuel J. ReichChief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Eddie J. Sullivan, PhD.President
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Alexandra Kropotova, MDEVP, Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Christoph Bausch, PhDEVP, Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Lucy ToEVP, Chief Financial Officer
| FY2023 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.